Hepatitis Drugs Market: Launches of New Drugs and Regulatory Approvals
Increasing number of government initiatives aimed at expanding drug coverage is expected to drive growth of the market. For instance, in 2018, the Ministry of Health and Long-Term Care of Ontario announced that all patients are eligible for Ontario Drug Benefit (ODP) irrespective of severity of their disease. In the same year, Thunder Bay group, a company that provides HIV/AIDS/Hepatitis C education and support services, expand its presence into medicines, as a result of successful negotiations between provinces and drug...
View full press release